 BOSTON, May 07, 2021 GLOBE NEWSWIRE -- Akouos, Inc. NASDAQ: AKUS, a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced the appointment of Dr. Kathy Reape as chief development officer. Dr. Reape brings over 20 years of experience in the pharmaceutical industry, including significant gene therapy translational and development expertise, to Akouos. 